CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 50 enrolled
Drug / intervention
pneumatic vest +1 moredevice
Likely dose
High frequency chest wall oscillation via pneumatic vest (frequency and intensity not specified)AI-extracted
Key inclusion· 5
  • Physician diagnosis of COPD, chronic bronchitis, and/or emphysema
  • FEV1/FVC ratio ≤70%
  • FEV1 ≤65%
  • Current or former smoker with ≥20 pack-year history
Key exclusion· 3
  • Other lung diseases (not COPD/chronic bronchitis/emphysema)
  • Co-morbid illnesses such as cancer, liver disease, or cardiomyopathy
  • Recent chest wall or abdominal trauma or surgery that would preclude using the vest

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00181207
NCT00181207Phase 4Completed

A Randomized, Sham-controlled, Double-blinded Pilot Study to Assess the Effects of High Frequency Chest Wall Oscillation (HFCWO) Therapy in Patients With Chronic Bronchitis

Johns Hopkins University·interventional·Posted Sep 16, 2005·Updated Oct 19, 2018

In Brief

A Phase 4 clinical trial evaluating pneumatic vest and placebo pneumatic vest for COPD and 2 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

The purpose of this study is to show that one form of mechanical airway clearance techniques, High Frequency Chest Wall Oscillation (HFCWO)using a pneumatic vest, will diminish exacerbations of COPD which will improve respiratory health status.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartMay 1, 2004
Primary CompletionNov 1, 2007
Study CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 20.8 years ago

Interventions

pneumatic vestdevice

placebo pneumatic vestother